Liliana Bar

This inventor holds 28 USPTO granted patents and 7 published patent applications, plus 7 CIPO patents and 16 EPO patents, primarily in Biomedical Innovations. Top assignees: Omrix Biopharmaceuticals Inc., Ethicon, Gmbh, Depuy Synthes Products, Inc.. Active years: 2002-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liliana Bar. Retrieved from https://idiyas.com/inventor/liliana-bar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 7)

% Patents Active = 82.1

CIPO Patents = 7 (Patent Applications = 3)

EPO Patents = 16 (Patent Applications = 16)

Average Co-Inventor Count = 3.6

ph-index = 6

Forward Citations = 138(Granted Patents)

Company Filing History:

23 out of 108

Omrix Biopharmaceuticals Inc.

Depuy Synthes Products, Inc.

patents

4. 2 out of 4

Opperbas Holding B.v.

where one patent can have more than one assignee

Years Active: 2002-2024

Loading Chart...

Areas of Expertise:

Thrombin Solution

Hemostatic Dressing

Immunoglobulin

Peripheral Vascular Disease

Cohn Fraction Paste

Spinal Disease Treatment

Gelatin Sponge

Plasmin Removal

Factor VIII

Nanofiltration

Cryoprecipitate

Micronization

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11993797 - Thrombin solution and methods of use thereof (2024-05-28),

2. 11225652 - Thrombin solution and methods of use thereof (2022-01-18),

3. 10722535 - Compositions derived from Cohn fraction paste and use thereof (2020-07-28),

4. 10479987 - Thrombin solution and methods of use thereof (2019-11-19),

5. 10039865 - Implantable device comprising a substrate pre-coated with stabilized fibrin (2018-08-07),

6. 9896716 - Protein assay (2018-02-20),

7. 9796770 - Immunoglobulin reduced in thrombogenic agents and preparation thereof (2017-10-24),

8. 9585918 - Treatment of peripheral vascular disease using umbilical cord tissue-derived cells (2017-03-07),

9. 9439997 - Reinforced absorbable multilayered hemostatis wound dressing (2016-09-13),

10. 9427490 - Gelatin sponge comprising an active ingredient, its preparation and use (2016-08-30),

11. 9365635 - Intravenous immunoglobulin composition (2016-06-14),

12. 9328338 - Method for removing a lytic enzyme from a heterogeneous mixture (2016-05-03),

13. 9326998 - Compositions suitable for treatment of spinal disease, disorder or condition (2016-05-03),

14. 9213035 - Protein assay (2015-12-15),

15. 9212357 - Thrombin solution and methods of use thereof (2015-12-15),

Certainly! Here is the article about inventor Liliana Bar:

Title: Unveiling the Inventive Brilliance of Liliana Bar

Introduction:

Liliana Bar, a pioneering female inventor hailing from Rehovot, Israel, has carved a remarkable path in the realm of innovation with her groundbreaking contributions. With an impressive portfolio of 28 patents to her name, Liliana Bar stands as a beacon of creativity and ingenuity in the field of biomedical research.

Latest Patents:

Among her latest patents is the innovative "Thrombin Solution and Methods of Use Thereof." This patent encompasses methods for the lyophilization of an aqueous thrombin solution, as well as the production of solid thrombin compositions through such methods. Liliana Bar's inventive prowess shines through in the development of these cutting-edge thrombin solutions, which hold immense promise in various medical applications.

Career Highlights:

Throughout her illustrious career, Liliana Bar has made significant contributions to renowned companies such as Omrix Biopharmaceuticals Inc. and Ethicon GmbH. Her tenure at these esteemed organizations has been characterized by a relentless pursuit of innovation and a steadfast commitment to advancing healthcare technologies. Liliana Bar's exceptional skill set and visionary approach have undoubtedly left an indelible mark on the field of biopharmaceuticals.

Collaborations:

Liliana Bar's collaborative efforts with esteemed colleagues such as Israel Nur and Roberto Meidler have further amplified the impact of her innovative ventures. Together, they have spearheaded pioneering research initiatives and fostered a culture of creativity and excellence within the realms of biomedical engineering and pharmaceutical sciences.

Conclusion:

In conclusion, Liliana Bar's unwavering dedication to innovation, coupled with her unparalleled expertise in biomedical research, underscores her status as a trailblazer in the domain of patent inventions. Her relentless pursuit of excellence and her transformative contributions continue to inspire future generations of inventors and researchers. Liliana Bar's legacy serves as a testament to the transformative power of ingenuity and the remarkable outcomes that can be achieved through relentless innovation.

Profile summary based on public USPTO records.